What is sepsis?
In recognition of Sepsis Awareness Month in September, Dr Gando, Editor-in-Chief of Journal of Intensive Care, tells more about the syndrome in this blog. Although old, sepsis is not yet fully characterized and this deregulated inflammation, which ...
BMC Blogs Network (blog) - Tue, 01 Sep 2015 04:47



Data From METEOR Pivotal Trial of Cabozantinib in Advanced Renal Cell ...
These receptor tyrosine kinases are involved in both normal cellular function and in pathologic processes such as oncogenesis, metastasis, tumor angiogenesis, and maintenance of the tumor microenvironment. COMETRIQ® (cabozantinib) is currently ...
MarketWatch - Mon, 24 Aug 2015 05:33

FDA Grants Breakthrough Therapy Designation to Exelixis' Cabozantinib for the ...
Yahoo Finance UK - Mon, 24 Aug 2015 05:33

Exelixis' cabozantinib gets US FDA breakthrough therapy designation to treat ...
pharmabiz.com - Wed, 26 Aug 2015 04:37



Future Science OA Special Issue Explores Current Protein Misfolding Disease ...
... observes that regrettably the mechanisms responsible for toxicity of protein aggregates are still not completely understood, and the number of protein targets whose misfolding and aggregation is being shown to be associated with the onset of ...
Cystic Fibrosis News Today - Fri, 28 Aug 2015 14:00



New Data on Autosomal-Dominant Alzheimer's Point to Early Fissures in the ...
An added caveat is that a number of different biological processes could underlie changes in diffusivity, as the measure itself is not tied to amyloid or tau pathology. That said, measuring microdamage might eventually offer an earlier marker of change ...
Alzforum - Fri, 07 Aug 2015 10:44

Amyloid Predicts Cognitive Decline in Genetic Alzheimer's
In genetic Alzheimer's, or autosomal dominant Alzheimer's disease (ADAD), patients are destined to develop the disease -- making them an ideal population for assessing the pathologic course of their specific disease. In these patients, who make up only ...
MedPage Today - Sun, 09 Aug 2015 08:56

Watch List: Galectin Therapeutics, Inc. (NASDAQ:GALT), Legacy Reserves (NASDAQ ...
The company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally occurring, readily-available plant materials as starting material in manufacturing ...
Stock Transcript - Tue, 01 Sep 2015 06:30

Parkinson's Disease and Its Management
Research has suggested that their formation may be secondary to refractory proteolytic processes involving abnormal breakdown or overproduction influenced by genetic mutations. ..... Staging of brain pathology related to sporadic Parkinson's disease.
P&T Community - Tue, 04 Aug 2015 20:45

Galectin Therapeutics Receives Average Rating of "Hold" from Analysts (NASDAQ ...
The Company's drug candidates are based on its method of targeting galectin proteins, which are key mediators of biologic and pathologic functions. The Company uses naturally occurring, readily-available plant materials as starting material in ...
Dakota Financial News - Tue, 18 Aug 2015 06:41

Quick Analysis: Galectin Therapeutics Inc. (NASDAQ:GALT), King Digital ...
Citizen Dispatch - Tue, 18 Aug 2015 02:33


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014